Site icon OncologyTube

WhatÂ’s Next for T-Cell Therapy and Avelumab for Merkel Cell Carcinoma

Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance discusses what’s next in the future for her clinical trial on t-cell therapy and avelumab for merkel cell carcinoma at the 2017 ASCO Annual Meeting in Chicago, IL.

Exit mobile version